Supreme Court of India

Glaxosmithkline Pharmaceuticals Limited (formerly Known as Smithkline Beecham Pharmaceuticals (india) Limited) v. Union of India & Ors.

Neutral citation
Reported as [2013] 12 S.C.R. 1120
Bench R.M. Lodha and Kurian Joseph JJ.
Decided 9 December 2013
Status Distinguished

INSC stands for INDIAN SUPREME COURT. A neutral citation scheme assigned by the Court itself, so a judgment can be cited without depending on a commercial law reporter. INSC is the neutral citation scheme assigned by the Supreme Court, so a judgment can be cited without depending on a commercial law reporter.

3 Supreme Court benches have cited this judgment.

From the headnote

DRUGS (PRICES CONTROL) ORDER, 1995: Para 14 (1) and 16 - Fixation of price of bulk drug or formulation - Compliance of - Held: Once the Government exercises power and fixes maximum sale price of bulk drugs specified in the First Schedule, there is ban to sell a bulk drug at a price exceeding the maximum sale price so fixed plus local taxes, if any - True import of paragraph 14(1) is that once the price notification is gazettec1, it takes effect immediately though its enforcement is postponed by fifteen days to enable the manufacturers and others to make suitable arrangements with regard to

Where later benches applied it

Of those, 1 distinguished · 1 referred to · 1 mentioned

Sign in free to read it

  • The full judgment, page by page, as published in the Supreme Court Reports
  • The ratio: what the Court held, verbatim, with the page it sits on
  • Every bench that relied on it, and every bench that argued against it
  • Search every reported judgment, by party, citation or question
  • Download the PDF, copy pinpoint citations ready for a filing
Sign in to read - for free

An email address, no password.